Products for Research Use Only
RegisterLogin

Tremelimumab

CAT: 0804-HY-P9918-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P9918-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Tremelimumab (Ticilimumab) is a fully human monoclonal antibody specific for cytotoxic T-lymphocyte antigen-4 (CTLA-4) and can be used for metastatic melanoma research[1].
CAS Number
745013-59-6
Product Name Alternative
Ticilimumab; CP-675206
UNSPSC
12352203
Target
CTLA-4
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/tremelimumab.html
Purity
99.50
Solubility
H2O
Smiles
[Tremelimumab]
Molecular Weight
(146.38 kDa)
References & Citations
[1]Comin-Anduix B, et al. Tremelimumab: research and clinical development. Onco Targets Ther. 2016 Mar 23;9:1767-76.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Launched

Alternative Products

CatalogName
abx831132-01Tremelimumab
GTR18874297-01Tremelimumab (Tremelimumab) ELISA KIT
JL58356-01Human Tremelimumab (Tremelimumab) ELISA Kit
GTR18320577-01Tremelimumab Antibody
DB651028Tremelimumab ELISA Kit
WA3701Research Grade Tremelimumab
KBI1705KRIBIOLISA™ Tremelimumab ELISA
E55B0400Tremelimumab (Reference antibody)
A2021-1mgTremelimumab (anti-CTLA-4)
ICH5184-100mgTremelimumab Biosimilar - Research Grade

Popular Products